Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 10 | 2025 | 84 | 2.420 |
Why?
|
| Neuroblastoma | 6 | 2025 | 550 | 1.680 |
Why?
|
| Immunotherapy, Adoptive | 7 | 2025 | 899 | 0.950 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2025 | 10 | 0.920 |
Why?
|
| Interleukin-15 | 1 | 2025 | 96 | 0.860 |
Why?
|
| Immunologic Memory | 1 | 2025 | 199 | 0.820 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2018 | 24 | 0.560 |
Why?
|
| beta Catenin | 2 | 2023 | 226 | 0.540 |
Why?
|
| L-Selectin | 2 | 2018 | 19 | 0.540 |
Why?
|
| Carcinoma, Papillary | 1 | 2018 | 94 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 728 | 0.360 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 992 | 0.280 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3682 | 0.240 |
Why?
|
| Gangliosides | 2 | 2025 | 73 | 0.240 |
Why?
|
| Lymphoma, B-Cell | 2 | 2018 | 148 | 0.240 |
Why?
|
| Receptors, Antigen | 2 | 2016 | 33 | 0.230 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2025 | 69 | 0.220 |
Why?
|
| Cytotoxicity, Immunologic | 4 | 2023 | 266 | 0.220 |
Why?
|
| Mutation | 1 | 2018 | 6226 | 0.210 |
Why?
|
| Lymphocyte Activation | 4 | 2023 | 686 | 0.200 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 15 | 0.200 |
Why?
|
| Cancer Vaccines | 2 | 2014 | 188 | 0.190 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 294 | 0.190 |
Why?
|
| Mice | 9 | 2025 | 18478 | 0.190 |
Why?
|
| Neoplasms | 3 | 2023 | 2956 | 0.180 |
Why?
|
| Mice, SCID | 3 | 2023 | 603 | 0.180 |
Why?
|
| Mice, Inbred NOD | 2 | 2023 | 315 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 666 | 0.160 |
Why?
|
| Antigen-Presenting Cells | 2 | 2016 | 133 | 0.150 |
Why?
|
| Immunotherapy | 2 | 2014 | 747 | 0.140 |
Why?
|
| Animals | 9 | 2025 | 34804 | 0.140 |
Why?
|
| Th1 Cells | 1 | 2018 | 159 | 0.140 |
Why?
|
| Interleukins | 1 | 2018 | 129 | 0.140 |
Why?
|
| Antigens, CD1d | 2 | 2014 | 21 | 0.130 |
Why?
|
| Humans | 14 | 2025 | 132013 | 0.120 |
Why?
|
| Salmonella typhimurium | 1 | 2014 | 43 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 1192 | 0.110 |
Why?
|
| Vaccines, Attenuated | 1 | 2014 | 176 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3043 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 866 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2016 | 761 | 0.100 |
Why?
|
| Cytokines | 2 | 2016 | 1365 | 0.100 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 402 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2016 | 2509 | 0.090 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2011 | 229 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2013 | 571 | 0.070 |
Why?
|
| Prognosis | 1 | 2018 | 5008 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3865 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2011 | 413 | 0.060 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 15 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 33 | 0.050 |
Why?
|
| Etanercept | 1 | 2023 | 47 | 0.050 |
Why?
|
| Protein Domains | 1 | 2023 | 260 | 0.050 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 183 | 0.050 |
Why?
|
| Adolescent | 2 | 2018 | 20544 | 0.050 |
Why?
|
| Monocytes | 1 | 2023 | 342 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 351 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 803 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2023 | 358 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 499 | 0.040 |
Why?
|
| Galactosylceramides | 1 | 2018 | 15 | 0.040 |
Why?
|
| Granzymes | 1 | 2018 | 48 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2018 | 59 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2018 | 240 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2018 | 382 | 0.030 |
Why?
|
| 4-1BB Ligand | 1 | 2014 | 11 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1754 | 0.030 |
Why?
|
| CD28 Antigens | 1 | 2014 | 81 | 0.030 |
Why?
|
| Retroviridae | 1 | 2014 | 194 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 294 | 0.030 |
Why?
|
| Female | 2 | 2018 | 70643 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 764 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 448 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 722 | 0.020 |
Why?
|
| Molecular Typing | 1 | 2011 | 34 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 104 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 146 | 0.020 |
Why?
|
| China | 1 | 2011 | 290 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 691 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 430 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 622 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 2725 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 930 | 0.020 |
Why?
|
| Antitubercular Agents | 1 | 2011 | 264 | 0.020 |
Why?
|
| Child | 2 | 2023 | 25765 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 827 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2679 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1609 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2697 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 12987 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 14736 | 0.010 |
Why?
|
| Male | 2 | 2013 | 64914 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 28968 | 0.010 |
Why?
|